Cognitive impairment no dementia - Neuropsychological and neuroimaging characterization of an amnestic subgroup

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 3, 2008, Pages 238-247

  Jacova, Claudia ^a   Peters, Kevin R ^b   Beattie, B Lynn ^a   Wong, Erick ^a   Riddehough, Andrew ^a   Foti, Dean ^a   Scheltens, Philip ^c   Li, David K B ^a   Feldman, Howard H ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRENT UNIVERSITY   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain fractional ratio; Cognitive impairment no dementia; Episodic memory; Medial temporal lobe; Mild cognitive impairment; MRI global brain volumetry; MRI visual rating; Neuropsychological testing

Indexed keywords

ADULT; AGED; AMNESIA; APTITUDE TEST; ARTICLE; CLINICAL ARTICLE; COGNITIVE IMPAIRMENT NO DEMENTIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ALZHEIMER DISEASE; AMNESIA; BRAIN; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 40549109559     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000115848     Document Type: Article

References (49)

1. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
2. Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauthier SG, et al: Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dement Geriatr Cogn Disord 2006;22:413-420.
3. Tuokko H, Frerichs R, Graham J, Rockwood K, Kristjansson B, Fisk J, et al: Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 2003;60:577-582.
4. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746.
5. Peters KR, Graf P, Hayden S, Feldman H: Neuropsychological subgroups of cognitively-impaired-not-demented (CIND) individuals: delineation, reliability, and predictive validity. J Clin Exp Neuropsychol 2005;27:164-188.
6. Peters KR, Graf P, Hayden S, Feldman H: Neuropsychological characterization of cognitively-impaired-not-demented (CIND) individuals: clinical comparison data. Clin Neuropsychol 2004;18:208-228.
7. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, et al: MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001;22:747-754.
8. Mega MS, Small GW, Xu ML, Felix J, Manese M, Tran NP, et al: Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space. Psychosom Med 2002;64:487-492.
9. Van Der Flier WM, van der Vlies AE, Weverling-Rijnsburger AW, de Boer NL, Admiraal-Behloul F, Bollen EL, et al: MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic. Int J Geriatr Psychiatry 2005;20:1060-1066.
10. Korf ES, Wahlund LO, Visser PJ, Scheltens P: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63:94-100.
11. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al: Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303-310.
12. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J: Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002;72:491-497.
13. Jack CRJ, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
14. Wolf H, Hensel A, Kruggel F, Riedel-Heller SG, Arendt T, Wahlund LO, Gertz HJ: Structural correlates of mild cognitive impairment. Neurobiol Aging 2004;25:913-924.
15. Jack CJR, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, et al: Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227-1231.
16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (IV-TR) ed 4, rev. Washington, American Psychiatric Association, 2000.
17. Rey A: L'examen clinique en psychologie. Paris, Presses Universitaires de France, 1964.
18. Geffen G, Moar KJ, O'Hanlon AP, Clark CR: Performance measures of 16- to 86-year-old males and females on the Auditory Verbal Learning Test. Clin Neuropsychol 1990;4:45-63.
19. Folstein MF, Folstein S, McHugh PR: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9(suppl 1):173-176.
21. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
22. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
23. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the Mini-Mental State examination by age and educational level. JAMA 1993;269:2386-2391.
24. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test: Adult Version. San Antonio, Psychological Corporation, 1987.
25. Wechsler D: WMS-III: Administration and Scoring Manual. San Antonio, Psychological Corporation, Harcourt Brace Jovanovich, 1997.
26. Rey A, Osterrieth PA: Translations of excerpts from Andre Rey's Psychological examination of traumatic encephalopathy and PA Osterrieth's The Complex Figure Copy Test. Clin Neuropsychol 1993;7:4-21.
27. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
28. Spreen O, Benton AL: Neurosensory Center Comprehensive Examination for Aphasia: Manual of Directions. Victoria, Neuropsychology Laboratory, University of Victoria, 1969.
29. Wechsler D: WAIS-III: Administration and Scoring Manual. San Antonio, Psychological Corporation, Harcourt Brace & Company,1997.
30. Lezak M, Howieson D, Loring DL: Neuropsychological Assessment. New York, Oxford University Press, 2004.
31. Kappos L, Traboulsee A, Constantinescu C, Eralinna JP, Forrestal F, Jongen P, et al: Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology 2006;67:944-953.
32. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-972.
33. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, Lawrence Baum Associates, 1988.
34. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
35. Steenhuis R, Ostbye T: Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol 1995;17:773-785.
36. Lopez OL, Becker JT, Jagust WJ, Fitzpatrick A, Carlson MC, DeKosky ST, et al: Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 2006;77:159-165.
37. Hodges JR, Erzinclioglu S, Patterson K: Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study. Dement Geriatr Cogn Disord 2006;21:380-391.
38. Kramer JH, Nelson A, Johnson JK, Yaffe K, Glenn S, Rosen HJ, Miller BL: Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2006;22:306-311.
39. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
40. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al: Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59-66.
41. Lambon Ralph MA, Patterson K, Graham N, Dawson K, Hodges JR: Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain 2003;126:2350-2362.
42. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ: Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005;19:520-531.
43. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux JM, et al: Cognitive process in preclinical phase of dementia. Brain 1998;121:135-141.
44. Xu Y, Jack CRJ, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, et al: Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000;54:1760-1767.
45. Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RL, Neto MR: Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 2002;14:59-72.
46. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, et al: Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007;64:108-115.
47. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, et al: Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;71:441-447.
48. Kabani NJ, Sled JG, Shuper A, Chertkow H: Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med 2002;47:143-148.
49. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, et al: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6:501-512.